Healthcare
Foresight invests £2.5m in ABL
Foresight Group's equity investment is supported by a debt package from Barclays
Evox Therapeutics raises £35.5m series-B
New backers include Redmile Group, GV, Cowen Healthcare Investments and Panacea Healthcare Venture
Lansdowne et al. in £25m series-B for Genomics
US-based drug developer Vertex Pharmaceuticals led the funding round for the genetic data researcher
Longitude leads £25m Kandy Therapeutics series-C
Recently founded biotech company will advance its menopause drug to the testing phase
PE-backed Vivalto Santé bolts on Capio's French division
French division of hospitals and clinics operator Capio is valued at around €455m
F2i in late-stage acquisition talks for Farmacrimi
Deal is part of the GP's buy-and-build strategy aimed at creating a group of pharmacies across Italy
Argos Wityu acquires AktivOptik
GP draws capital from its seventh vehicle to buy the optician and hearing care chain
Almi Invest backs Beactica
Funds raised are intended to accelerate the drug developer's pipeline of novel cancer therapeutics
Capricorn invests in C-Lecta
Capricorn draws capital for the investment from Capricorn Sustainable Chemistry Fund
Healthcare under observation among European GPs
Digitalisation and vendors that are increasingly receptive to PE are providing opportunities in the sector
Star Capital buys Educom via DPH
Educom will be owned by DPH, a company established by Star to pursue its buy-and-build strategy
ADV leads £3m series-A for Healthera
Previous backer Cambridge Enterprise and newcomer Future Care Capital also take part in the funding
WCAS takes Abzena private for £34.4m
Biotechnology and pharmaceutical company has previously received backing from a number of VCs
Catapult, Mercia in funding round for Rinicare
NPIF - Mercia Equity Finance is part of the Northern Powerhouse Investment Fund
H2 buys Healthcare 21
GP plans to merge the two companies and create a combined group with operations across Europe
VC firms invest £2.4m in BioBeats
IQ Capital, Oxford Sciences Innovation and White Cloud Capital lead the round
VC-backed Orchard Therapeutics raises $150m series-C
UK-based biotechnology company is registering and launching three treatments for rare disorders
Connect leads $3m round for OurPath
Connected healthcare programme is designed to help type 2 diabetese patients reverse the disease
Andera and LSP lead $84m series-B for Artios
Biotech firm will undertake clinical proof-of-concept trials for its DNA polymerase theta programme
Therachon nets $60m mezzanine from Novo et al.
Existing investors Versant Ventures, OrbiMed, BPI France and Inserm Transfert Initiative also take part
Nordic Capital acquires Excent Tandtechniek
Deal was made as an add-on to Nordic Capital's European Dental Group platform
H2 acquires Aquilant from UDG for up to €23m
Deal for the healthcare products and services provider will see the GP pay €20.5m up front
Paragon buys Innere Medizin from UCB
Paragon draws equity from its €412m buyout fund, which held a final close in 2017
VC firms back $55m series-B for ReViral
Round is led by New Leaf Venture Partners and Novo Ventures, alongside new and existing investors